Cas:13446-71-4 rubidium chlorate manufacturer & supplier

Chemical Name:rubidium chlorate

CAS.NO:13446-71-4

Synonyms:rubidium(1+) chlorate;Rubidiumchlorat;Rubidiumchlorate (6CI,7CI);Rubidium chlorate (RbClO3);rubidium chlorate;Chloric acid,rubidiumsalt (8CI,9CI)

Molecular Formula:ClO₃Rb

Molecular Weight:168.91900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:3.190

Index of Refraction:

PSA:57.20000

Exact Mass:167.86500

LogP:0.33310

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like rubidium(1+) chlorate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Chloric acid,rubidiumsalt (8CI,9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Rubidiumchlorat Use and application,Rubidiumchlorate (6CI,7CI) technical grade,usp/ep/jp grade.

Related News: In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. rubidium chlorate manufacturer Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. rubidium chlorate supplier In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells. rubidium chlorate vendor Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� rubidium chlorate factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.